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Abstract
Background: Presenilin 1(PS1) is the catalytic subunit of c-secretase, the enzyme responsible for the Ab C-terminal cleavage
site, which results in the production of Ab peptides of various lengths. Production of longer forms of the Ab peptide occur
in patients with autosomal dominant Alzheimer disease (AD) due to mutations in presenilin. Many modulators of c-
secretase function have been described. We hypothesize that these modulators act by a common mechanism by
allosterically modifying the structure of presenilin.
Methodology/Principal Findings: To test this hypothesis we generated a genetically encoded GFP-PS1-RFP (G-PS1-R) FRET
probe that allows monitoring of the conformation of the PS1 molecule in its native environment in live cells. We show that
G-PS1-R can be incorporated into the c-secretase complex, reconstituting its activity in PS1/2 deficient cells. Using Fo ¨rster
resonance energy transfer (FRET)-based approaches we show that various pharmacological and genetic manipulations that
target either c-secretase components (PS1, Pen2, Aph1) or c-secretase substrate (amyloid precursor protein, APP) and are
known to change Ab42 production are associated with a consistent conformational change in PS1.
Conclusions/Significance: These results strongly support the hypothesis that allosteric changes in PS1 conformation
underlie changes in the Ab42/40 ratio. Direct measurement of physiological and pathological changes in the conformation of
PS1/c-secretase may provide insight into molecular mechanism of Ab42 generation, which could be exploited
therapeutically.
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Introduction
c-Secretase is an enzymatic complex composed of at least four
proteins: presenilin 1 or presenilin 2 (PS1 or PS2), Nicastrin, Pen2
and Aph1 [1–5], with presenilin representing the catalytic core [6–
9]. Change in the precision of the APP substrate cleavage by c-
secretase result in change in the Ab42/40 ratio. Ab42 represents a
highly fibrillogenic species that is more prone to form neurotoxic
oligomers leading to synaptic dysfunction and neuronal death
[10,11]. An increase in the Ab42/40 ratio has been implicated in
Alzheimer’s disease (AD) pathogenesis. However, it remains
unclear what cellular and molecular factors are responsible for
the shift in APP c-cleavage site towards toxic Ab42 species.
A number of genetic and pharmacological manipulations
targeting either c-secretase complex or its APP substrate have
been demonstrated to alter Ab42/40 ratio. For example, familial
AD-linked mutations in PS1, elongation of Pen2 N-terminus (NT),
or expression of Aph1B isoform, increase the Ab42/40 ratio [12–
14]. Targeting the APP substrate directly by introducing
mutations near the APP c-secretase cleavage site [15,16] modifies
Ab42/40 ratio. In addition, a subset of Ab42-lowering non-steriodal
anti-inflammatory drugs [17,18] act as c-secretase modulators
(GSMs) indirectly via binding to the APP substrate [19]. These
APP-targeting manipulations may alter APP conformation, its
positioning within the membrane, APP substrate presentation to c-
secretase, and/or stabilize PS1 in a certain conformation, and thus
affect the site of APP cleavage by c-secretase.
In the present study we test the hypothesis that Ab42/40 ratio
correlates with allosteric PS1/c-secretase conformation. We have
previously developed an assay to monitor PS1 conformation in
fixed and permeabilized cells by labeling different domains of PS1
with fluorophore-tagged antibodies. Based on our findings [20,21]
we hypothesize that the mature PS1 molecule may exist in
equilibrium of two conformational states: ‘‘open’’ and ‘‘closed’’,
corresponding to a predominant cleavage of APP at Ab40 and
Ab42 sites, respectively. To test the hypothesis that multiple GSMs
act by allosterically influencing PS1 conformation, and to directly
monitor PS1 conformation in live cells, we developed a new assay
that monitors proximity between the PS1 NT and the major
cytosolic loop between PS1 transmembrane domains 6 and 7
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generated by tagging PS1 NT with green fluorescent protein (GFP)
and TM6-7 loop with red fluorescent protein (mRFP). We
demonstrate that various Ab42 raising manipulations, including
direct manipulations of the c-secretase components (Pen2, Aph1
and PS1) or pharmacological targeting of APP (fenofibrate) lead to
a common conformational change of PS1: closer proximity of the
PS1 NT and TM6-7 loop. Conversely, treatment with the Ab42–
lowering agent (ibuprofen) moves PS1 NT and loop farther apart.
Thus, we found that a broad range of Ab42-altering manipu-
lations, regardless of their precise molecular mechanism or their
target, lead to a consistent change in PS1 conformation. This
suggests that PS1 conformation could be a reliable predictor of Ab
production, and presents an allosteric modulation of the
‘‘pathogenic’’ PS1 conformation as an attractive therapeutic
strategy.
Results
GFP-PS1-RFP Probe Reconstitutes c-Secretase Activity
GFP-PS1-RFP (G-PS1-R) construct was generated to monitor
PS1 conformation (PS1 NT-loop proximity) in live cells. For this,
green fluorescent protein (GFP) was fused to the PS1 N-terminus
and red fluorescent protein (mRFP) was inserted into the TM6-7
loop domain (Figure 1A). The resulting G-PS1-R fusion protein
represents an ideal molecular probe for FRET-based analysis with
a donor and an acceptor fluorophore in a 1:1 ratio. When
expressed in cells, the G-PS1-R probe shows perinuclear
distribution of GFP and RFP, a pattern similar to that of
endogenous wt PS1 (Supplementary Figure S1, and
Figure 1B). To examine whether the G-PS1-R probe can traffic
though the secretory pathway to the plasma membrane, we
assessed the expression pattern of the G-PS1-R protein in cells by
using total internal reflection fluorescence microscopy (TIRFM),
which detects fluorescent signal within 100 nm of the cell surface.
A dotty pattern of the TIRFM signal was detected at the cell
surface in G-PS1-R expressing cells, indicating that a few percent
of the G-PS1-R molecules reach the cell surface (Figure 1C).
Next, we asked whether the G-PS1-R probe could be
incorporated into the c-secretase complex to exert its enzymatic
function. To test this, we monitored the ability of G-PS1-R to
undergo endoproteolysis, and to cleave APP and Notch c-secretase
substrates. First, CHO cells were transiently transfected with G-
PS1-R or infected with lenti-G-PS1-R, lysed, and analyzed by
Western blot. As shown in Figure 1D, G-PS1-R undergoes
endoproteolysis to generate ,60 kDa PS1 NTF-GFP and
,40 kDa CTF-RFP. Noticeably, the endogenous PS1 was
reduced in cells transfected with G-PS1-R, suggesting that other
components of the c-secretase are forming a complex with
exogenous G-PS1-R, destabilizing endogenous wild-type (wt)
PS1 (the ‘replacement phenomena’) (Figure 1D, bottom
panel).
To determine if G-PS1-R is able to reconstitute c-secretase
activity, PS1/2 dKO MEF cells were transfected with G-PS1-R,
and APP processing was assessed by monitoring APP C-terminal
fragment (CTF) levels in cell lysate. Using an APP C-terminal
specific antibody, we observed the reduction in the level of APP
CTFs in PS1/2 dKO cells transfected with G-PS1-R compared to
that in the ‘‘no PS’’ lane (Figure 1 Etop panel ). This indicates
that APP CTFs, immediate substrates of the c-secretase, are
cleaved by G-PS1-R containing c-secretase complex. Further-
more, when PS1/2 dKO MEF cells were transfected with another
immediate substrate of c-secretase, the constitutively active NEC
construct, the cleavage product Notch intracellular domain
(NICD) was detected only in G-PS1-R co-transfected cells
(Figure 1E bottom panel ). Thus, we conclude that G-PS1-R
can assemble into the c-secretase complex and is able to
reconstitute c-secretase activity in PS1/2 dKO cells.
Detection of Inter- versus Intra-Molecular FRET Using G-
PS1-R Probe
To test whether GFP on the N-terminus and RFP in the loop
domain of PS1 are close enough to support FRET, CHO cells
were transfected with GFP-PS1 (negative control) or G-PS1-R
constructs, and analyzed by Fluorescence Lifetime Imaging
Figure 1. Expression, processing, and activity of the G-PS1-R
protein. (A)- Schematic representation of the G-PS1-R construct. The
GFP is fused to the N-terminus of PS1, and serves as a donor
fluorophore in the FRET assays, whereas RFP (an acceptor fluorophore)
is introduced by PCR into the TM6-7 loop region of PS1 between amino
acids 351 and 352. (B–C) The expression of the G-PS1-R in CHO cells. (B)
-Epi-fluorescent signal shows strongest fluorescence intensity in the
perinuclear region of the cell by confocal microscopy. (C) - Cell surface
expression of the G-PS1-R probe shown by TIRFM. A speckled pattern of
the TIRF signal indicates that G-PS1-R protein reaches the cell surface.
(D) CHO cells were transfected with G-PS1-R construct and cell lysates
were subjected to the western blot analysis. (D, Top) G-PS1-R
undergoes endoproteolysis to yield PS1 NTF and CTF. A ,100 kDa
full-length G-PS1-R, ,50 kDa PS1 NTF-GFP and ,40 kDa CTF PS1-RFP
were observed by blotting with the anti-GFP antibody. Asterisk: non-
specific bands. (D, Bottom) Blotting by anti-PS1 CTF is shown. Full-
length G-PS1-R as well as ,40 kDa PS1-RFP CTF were detected. Note,
that endogenous PS1 CTF is reduced in the G-PS1-R expressing CHO
cells (replacement phenomena). (E) G-PS1-R reconstitutes c-secretase
activity in PS1/2 dKO MEF cells. (E, Top) APP CTF is reduced in PS1/
2 dKO MEF cells expressing G-PS1-R; probed with anti-APP CTF
antibody. (E, Bottom) PS1/2 dKO cells were transfected with NEC with
or without G-PS1-R construct, lysed, and analyzed by western blotting
using NICD-specific (Val1744) antibody. Note that NICD can only be
observed in cells expressing G-PS1-R.
doi:10.1371/journal.pone.0007893.g001
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was measured in GFP-PS1 transfected cells in the absence of RFP
acceptor (Table 1). As expected, GFP lifetime significantly
shortens in the presence of the RFP acceptor in G-PS1-R
transfected cells, compared to that in the G-PS1 expressing cells.
This indicates FRET, i.e. close proximity between GFP-PS1 NT
and RFP-PS1 loop. Since PS1 dimers have been previously
reported, [22-24] we tested how much of the FRET signal is
contributed by inter-molecular (PS1 dimers) versus intra-molecu-
lar (single PS1 molecule) interaction. For this, dilution of the G-
PS1-R probe with untagged PS1 DNA was prepared for the
transfection. We reasoned that dilution of the G-PS1-R probe by
the wt PS1 would reduce inter-molecular FRET via competitive
inhibition of the G-PS1-R/G-PS1-R dimer formation, whereas G-
PS1-R intra-molecular FRET would not be affected. GFP-PS1
NT to RFP-PS1 loop FRET efficiency (GFP lifetime shortening)
was monitored by FLIM in cells transfected with G-PS1-R only
(presumed mixture of intra- and inter-molecular FRET), co-
transfected with G-PS1-R and untagged wild type PS1 in 1:3 ratio
(mostly intra-molecular FRET), and in cells co-transfected with
GFP-PS1 and PS1-RFP constructs (inter-molecular FRET only).
We found that the GFP lifetime did not significantly change when
G-PS1-R was diluted by unlabeled PS1, indicating that the vast
majority of the detected FRET signal was due to intra-molecular
FRET (Table 1). In addition, GFP-PS1 lifetime in GFP-PS1 and
PS1-RFP co-transfected cells (inter-molecular FRET) was signif-
icantly longer, comparing to that in the G-PS1-R transfected cells.
This further supports the notion that the FRET signal detected
with the G-PS1-R probe originates mostly from intra-molecular
FRET.
Manipulation of the c-Secretase Components Leads to
Altered Ab42/40 Ratio and Correlates with PS1
Conformational Change
Based on our previous findings in fixed cells, we have
hypothesized that mature PS1 molecules may exist in at least
two conformational states: ‘‘open’’ and ‘‘closed’’ [20,21]. Accord-
ing to this model, familial Alzheimer’s disease (FAD) PS1
mutations shift the equilibrium to favor a ‘‘close’’ NT-CT
conformation (with NT-CT closer together) and stabilize an
alignment of the PS1/c-secretase active site with the APP substrate
to favor predominant cleavage of APP at the Ab42 position. Now
we test whether the G-PS1-R probe can monitor changes in PS1
conformation in live cells.
First, to determine if the G-PS1-R probe adopts a different
conformation in the presence of FAD-linked mutation, either wild-
type G-PS1-R probe or G-PS1-R probe incorporating the L166P
PS1 mutation (L166P G-PS1-R) was transfected into CHO cells
and the NT-loop proximity was analyzed by FLIM. We found that
the GFP lifetime in the L166P G-PS1-R expressing cells was
noticeably shorter (Table 2), compared to that in the wt G-PS1-R
transfected cells, indicating that L166P G-PS1-R adopts a ‘‘close’’
NT-loop conformation.
Isoo et al. [13] reported recently that introducing a structural
change to the N-terminus of one of the c-secretase complex
components, Pen2, leads to an increase in the Ab42 production.
Since we have previously observed that a change in the Ab42/40
ratio due to familial AD mutations correlates with a change in the
PS1 NT-CT proximity we hypothesized that an elongation of the
Pen2 NT may have an effect on PS1 conformation similar to that
of FAD PS1 mutations.
To test this, CHO cells were co-transfected with G-PS1-R and
either wt Pen2 or Pen2 with elongated NT due to a flag tag (flag-
Pen2). We found that in the conditioned media of the flag-Pen2
transfected cells the Ab42/40 ratio was increased by ,1.6 fold,
compared to that in the Pen2 transfected cells, confirming the data
by Isoo et al. [13]. Correspondingly, when we monitored G-PS1-R
conformation in living cells by the FLIM assay we found that cells
co-transfected with flag-Pen2 displayed closer PS1 NT-loop
proximity compared to that in the wt Pen2 transfected cells, as
reflected by the shortening of the average donor fluorophore
lifetime in flag-Pen2 expressing cells (Table 3). We used an
alternative approach to confirm these findings; our previously
validated PS1 NT-CT conformation FLIM assay in fixed and
immunostained cells. The cells were double-immunostained with
the previously reported PS1 NT-CT pair of antibodies [21] as well
as with the PS1 NT-loop pair of antibodies, a new assay that
matches the G-PS1-R NT-loop conformation assay. The primary
antibodies were fluorescently labeled with Alexa488 (A488) as a
donor and Cy3 as an acceptor fluorophores. We found a
statistically significant shortening of the donor lifetime per cell in
the flag-Pen2 transfected cells in both PS1 NT-CT and PS1 NT-
loop assays (Table 3). This indicates that elongation of the Pen-2
N-terminus correlates with the change in PS1 conformation,
which in turn leads to an increase in Ab42 generation.
We have recently reported that different isoforms of another c-
secretase component, Aph1 (Aph1A vs. Aph1B), support differen-
tial c-secretase activity, with Aph1B containing c-secretase
complexes yielding a higher Ab42/40 ratio [14]. Using the
antibody-based FLIM assay we showed that PS1 has shorter
distance between its NT and CT in cells containing Aph1B alone,
compared to that in Aph1A expressing cells [14]. Thus, we asked
whether conformational changes in the PS1 molecule induced by
different Aph1 isoforms could be detected in live cells by the G-
PS1-R probe. MEF cells expressing either all Aph1 isoforms (wt
Aph1), or exclusively Aph1A or Aph1B containing c-secretase
complexes were transfected with G-PS1-R, and NT-loop distance
was evaluated by the FLIM analysis. We found that the lifetime of
Table 1. Detection of inter- vs. intra-molecular FRET using
G-PS1-R probe.
Condition Donor Acceptor Donor lifetime (psec)
G-PS1 GFP-NT none 2097678 (n=11)
G-PS1-R GFP-NT RFP-loop 17836197 (n=14)*
G-PS1-R:wtPS1
(1:3)
GFP-NT RFP-loop 17526117 (n=14)*
G-PS1+PS1-R
(1:1)
GFP-NT RFP-loop 1983662 (n=13)#
*:p ,0.001 vs G-PS1,
#:p ,0.05 vs G-PS1.
doi:10.1371/journal.pone.0007893.t001
Table 2. The effect of L166P mutant on G-PS1-R
conformation.
Condition Donor Acceptor Donor lifetime (psec)
G-PS1 GFP-NT none 2074627 (n=7)
G-PS1-R GFP-NT RFP-loop 17426244 (n=15)
L166P G-PS1-R GFP-NT RFP-loop 14886145 (n=15)*
*:p ,0.001 vs G-PS1-R.
doi:10.1371/journal.pone.0007893.t002
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cells, compared to that in fibroblasts expressing Aph1A or wild-
type Aph1 (Table 4). These results further support the notion that
PS1 adopts a ‘‘close’’ conformation in live cells expressing Aph1B-
containing c-secretase complexes, and such PS1 conformation
may be responsible for a shift towards the Ab42 cleavage site.
Pharmacological Manipulations of the Ab42 Production
Are Associated with a Change in G-PS1-R Conformation
Several compounds, referred to as c-secretase modulators
(GSMs), have been shown to selectively affect production of Ab
species of different lengths by affecting the APP c-secretase
cleavage site. Weggen et al. [17] reported that the group of
NSAIDs shifted the c-secretase cleavage site on APP from the
Ab42 position to Ab38, selectively reducing Ab42 generation.
Another set of compounds, such as fenofibrate, mimicked the
effect of FAD mutations by increasing Ab42 production [13,25].
Now we explore whether we can detect G-PS1-R conformational
change in live cells due to GSM treatment. For this, CHO cells
transfected with G-PS1-R probe were treated with either 100 mM
fenofibrate or DMSO. The conditioned media was collected for
Ab specific ELISA and the cells were used for the analysis of PS1
NT-loop proximity by FLIM. The Ab ELISA revealed that in cells
treated with fenofibrate the level of secreted Ab40 was reduced by
,42% and the level of Ab42 was increased by ,36%. FLIM
analysis showed that fenofibrate treatment leads to a significant
shortening of the GFP lifetime in cells expressing G-PS1-R
construct, compared to that in DMSO treated cells (Table 5),
indicating a decrease in the GFP-PS1-NT and RFP-PS1-loop
proximity.
Similarly, our previously validated endogenous PS1 NT-CT
conformation FLIM assay in fixed and immunostained cells
showed statistically significant shortening of the donor (Alexa 488)
lifetime in cells treated with fenofibrate, compared to that in the
DMSO treated cells (Table 5). These data suggest that fenofibrate
alters the conformation of the PS1 molecule to favor a ‘‘close’’ PS1
NT-loop and PS1 NT-CT proximity, which correlates with a shift
in the APP c-cleavage site.
Detection of the PS1 Conformation in Live Cells by
Spectral FRET
While FLIM approach provides high spatial resolution, each
FLIM image takes minutes to acquire. The high temporal
resolution of Spectral FRET analysis allows detection of more
rapid changes in the FRET efficiency in live cells transfected with
fluorescent proteins and enables monitoring these changes on a
high throughput basis. First, we established optimal settings for the
spectral imaging of the G-PS1-R transfected cells, and selected
spectral windows in which changes in the donor and acceptor
fluorescence intensity due to FRET are the most evident
(Figure 2A). A construct encoded by RFP fused to GFP in a
1:1 ratio via a short linker (R-G fusion) was used as a positive
control of the energy transfer, whereas G-PS1 (no acceptor) was
used as a negative control. When cells transfected with the R-G
fusion construct were activated by a 488 nm laser, the emission
spectrum changed from that of the G-PS1, yielding a large spike at
the 598 nm as a result of the energy transfer from the GFP donor
to the RFP acceptor. Thus, we determined the ratio of
fluorescence intensity at the 598 nm to that at the 513 nm
(emission peak of the GFP) as a readout for the FRET efficiency:
higher 598/513 ratio indicates higher FRET efficiency, and closer
proximity between the fluorophores.
When cells transfected with the G-PS1-R probe were activated
by the 488 nm laser, we observed a shift in the emission spectra,
indicating the presence of FRET from GFP to RFP, and resulting
in a significantly higher 598/513 ratio, compared to that of the G-
PS1 control. Next, we confirmed that the spectral FRET assay can
detect subtle conformational differences between the wild type and
L166P mutant G-PS1-R molecules. As shown in Figure 2A, the
emission spectrum curve of the L166P G-PS1-R showed a small
‘hump’ at 598 nm, indicating a higher FRET efficiency compared
to that of the wild type G-PS1-R. We observed a small but
statistically significant increase in the average 598/513 ratio
Table 3. Manipulation of Pen-2 lead to altered Ab42/40 ratio as
well as PS1 conformation.
Condition Donor Acceptor Donor lifetime (psec)
wt/flag-Pen2 GFP-NT none 2017622 (n=12)
wt Pen2 GFP-NT RFP-loop 17196135 (n=19)
flag-Pen2 GFP-NT RFP-loop 14306194 (n=22)*
wt/flag-Pen2 Alexa488-NT none 2223614 (n=6)
wt Pen2 Alexa488-NT Cy3-loop 1852659 (n=10)
flag-Pen2 Alexa488-NT Cy3-loop 1799689 (n=10)**
wt Pen2 Alexa488-NT Cy3-CT 1802661 (n=10)
flag-Pen2 Alexa488-NT Cy3-CT 16996109 (n=10)***
*:p ,0.05 vs wt Pen2,
**:p ,0.05 vs wt Pen2,
***:p ,0.05 vs wt Pen2.
doi:10.1371/journal.pone.0007893.t003
Table 4. Manipulation of Aph1 lead to altered PS1
conformation.
Condition GFP donor RFP acceptor Donor lifetime (psec)
wt fibroblast GFP-NT none 2110635 (n=26)
wt fibroblast GFP-NT RFP-loop 1867680 (n=22)
Aph1A GFP-NT RFP-loop 1874658 (n=22)
Aph1B GFP-NT RFP-loop 1766684 (n=22)*
*:P ,0.001 vs wt, Aph1A.
doi:10.1371/journal.pone.0007893.t004
Table 5. Pharmacological modulation of Ab42 by fenofibrate
changes conformation of G-PS1-R.
Condition Donor Acceptor Donor lifetime (psec)
DMSO/Fenofibrate GFP-NT None 201368( n=6 )
DMSO GFP-NT RFP-loop 1772663 (n=11)
Fenofibrate GFP-NT RFP-loop 1666626* (n=10)
DMSO/Fenofibrate Alexa488-NT none 2083636 (n=7)
DMSO Alexa488-NT Cy3-CT 1823625 (n=15)
Fenofibrate Alexa488-NT Cy3-CT 1698658** (n=16)
*:p ,0.05 vs DMSO,
**:p ,0.02 vs DMSO.
The representative experiment is shown; total four independent experiments
were performed.
doi:10.1371/journal.pone.0007893.t005
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This result indicates that in the presence of the L166P mutation,
GFP at the PS1 NT is closer to or more directly aligned with the
RFP in the TM6-7 loop, giving rise to more efficient energy
transfer from G to R, compared to that in the wt PS1 molecules.
To visualize structural differences between the G-PS1-R
molecules in different subcellular compartments of the same cell,
pseudo-colored ratiometric images of the 598/513 intensity were
generated by Image J program after background subtraction.
Several regions of interest (ROI) were randomly selected within
the cell expressing G-PS1-R (Supplementary Figure S2A) and
the 598/513 ratio was calculated in each ROI. As expected, ROIs
located at the cell periphery yield higher 598/513 ratio (more
green-to-red pixels in the pseudo-colored Spectral FRET image),
compared to the ROI adjacent to the nucleus (predominantly blue
pixels, Supplementary Figure S2B). This distribution is very
similar to that in HEK cells transfected with G-PS1-R and
analyzed by FLIM (Supplementary Figure S2C). The pseudo-
colored FLIM image shows shorter lifetime of the donor GFP at
the periphery of the cells (red pixels), indicating ‘closer’ NT-loop
conformation of the G-PS1-R probe at/near the cell surface.
Thus, both FLIM and spectral FRET imaging in live cells revealed
that G-PS1-R molecules adopt more ‘‘close’’ NT-loop conforma-
tion as they move towards the cell surface, a pattern which is
identical to that of previously observed endogenous PS1 [21].
Finally, we asked if the effect of GSMs treatment on PS1
conformation could be detected by spectral FRET in live cells. To
test this, HEK293 cells were infected with G-PS1-R-lenti viral
constructs. 24 hrs after the infection, cells were treated with either
100 mM fenofibrate (closes PS1 conformation) or 400 mM
ibuprofen (opens PS1 conformation [20]) for 24 hours followed
by the 598/513 ratio analysis. Control cells were treated with
vehicle (DMSO and ethanol, respectively). As expected, fenofi-
brate treatment resulted in a spectral shift similar to that observed
for the L166P G-PS1-R construct. We detected a significant
increase in the 598/513 ratio in the presence of fenofibrate
(Figure 3A), which indicates that fenofibrate treatment induces
the ‘‘closed’’ conformation of PS1.Conversely, ibuprofen treat-
ment leads to a reduced 598/513 ratio (Figure 3B), inducing an
‘‘open’’ PS1 conformation. Thus, G-PS1-R conformation changes
in response to agents that selectively modulate Ab42 production in
live cells.
Discussion
An aggregation and deposition of amyloid b (Ab) containing
plaques is a common feature of normal aging and the AD brain. A
shift towards an increased proportion of the longer, highly
fibrillogenic and neurotoxic Ab species (i.e., Ab42) in the brain
has been associated with the neurodegeneration leading to AD.
Blocking Ab production can be a therapeutic target. However,
direct inhibition of c-secretase activity may cause undesirable side
effects due to disruption of the normal physiological function of
numerous c-secretase substrates, including APP itself [26] and
Notch [27]. Instead, modulators of the site at which c2secretase
cleaves APP have been developed by screening libraries of
compounds, or noted by genetic manipulations [13,17,25].
However, the precise molecular and cellular mechanism under-
lying the resultant changes in the Ab42/40 ratio is unknown. We
propose a hypothesis of ‘‘structure-function correlation’’ implying
that structural changes in the PS1/c-secretase are linked to the
precision of c-cleavage of APP to yield Ab species of different
lengths. Our data suggest that changes in the structure of multiple
members of the c-secretase complex, or even APP itself, can
Figure 2. Detection of the PS1 conformation in living cells by spectral FRET. (A) HEK293T cells were transfected with designated constructs
and activated by the 488 nm laser. Vertical axis shows the ratio of intensities within the 513 nm to 641 nm spectral range normalized by the intensity
at 513 nm. The GFP-RFP fusion construct (red) shows large ‘hump’ centered on 598 nm, compared to G-PS1 (purple) fluorescence intensity due to
FRET, i.e., energy transfer from GFP to RFP. L166P G-PS1-R (green) shows smaller but significant (p,0.001) increase in the 598/513 ratio, compared to
that in the wild-type G-PS1-R expressing cells (blue). (B) HEK293Tcells were transfected with either G-PS1-R or L166P mutant G-PS1-R construct. Equal
numbers of cells (n=277) were randomly chosen from each condition and cell number was plotted against the 598/513 ratio. Note that the
histogram is shifted to the right for L166P mutants, indicating an increase in the number of cells that exhibit higher 598/513 ratio, i.e., closer PS1 NT-
loop proximity (p,0.001).
doi:10.1371/journal.pone.0007893.g002
PS1 Conformation and Ab
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change in c-secretase/APP interactions and alters the exact
cleavage site of APP.
Very little is currently known about the structure of the PS1/c-
secretase complex due to its complexity and the difficulty of
crystallizing multi-pass membrane proteins. Several studies that
use serial deletions and co-immunoprecipitation [28], substituted
cysteine accessibility method [13,29,30] or electron microscopy-
based analyses [31] reported that PS1/c-secretase may form a
ring-like pore within the hydrophobic environment of a mem-
brane. However, all these studies required lysing of the cells and/
or were performed using isolated c-complexes. To test the
hypothesis of PS1/c-secretase structure-function correlation in
living cells and to accurately report molecular changes in PS1 in its
native environment, a fluorescent probe is required that
adequately responds to various experimental manipulations
associated with alterations in the Ab42/40 ratio. In this report,
we present and fully characterize a novel probe, GFP-PS1-RFP
fusion protein, which exploits NT-loop proximity as a readout of
PS1 conformation in live cells. We employ a molecular imaging
methodology, such as FRET-based microscopy, to show that this
probe allows monitoring, and accurately reflects consistent
structural changes of the PS1 molecule in live cells, and that
these changes closely correlate with changes in the Ab42/40 ratio.
We verified that G-PS1-R protein can be cleaved into NTF and
CTF, can traffic to the plasma membrane, which is critical for the
metabolism of some substrates, and can be incorporated into the
c-secretase complex to support enzymatic activity in cells lacking
both presenilin 1 and presenilin 2. Moreover, using both FLIM
and spectral FRET approaches we determined that G-PS1-R
protein adopts ‘‘close’’ or ‘‘open’’ PS1 NT-loop proximity in
response to various Ab42-raising or lowering manipulations,
respectively. These manipulations include introducing familial
Alzheimer’s disease L166P PS1 mutation, structural change in the
Pen2 N-terminus, expressing Aph1B or Aph1A isoform, or
pharmacological treatment (fenofibrate, ibuprofen). We show that
data obtained using G-PS1-R probe are in agreement with our
previous findings using FLIM analysis of fixed, permeabilized, and
immunostained cells, that utilized either NT-CT or NT-loop
proximity to monitor PS1 conformation [14,20,21]. Since
antibody-based FLIM analysis is based on immunolabeling of
endogenous and/or untagged PS1 molecules, these results confirm
that the G-PS1-R probe is a reliable indicator of PS1
conformation in living cells.
The finding that the G-PS1-R probe acquires ‘‘open’’
conformation in response to ibuprofen treatment and ‘‘close’’
NT-loop proximity in response to fenofibrate is very interesting
since it has recently been shown that these agents target APP
substrate [19], and not c-secretase complex itself as previously
believed [32,33]. This indicates that modifications in the substrate
could allosterically affect conformation of the enzyme. In line with
this finding, we have previously showed that APP mutations which
reduce Ab42 lead to an ‘‘open’’ [15], whereas mutations that
increase Ab42 induce ‘‘close’’ [16] conformation of the PS1
molecule. Thus, altered presentation of the APP substrate to c-
secretase, driven by either APP mutations or by binding of the
pharmacological agents to APP could, in turn, allosterically affect
PS1 conformation.
Collectively, our data demonstrate that regardless of the nature
(genetic or pharmacological GSMs) or precise target (i.e. PS1, Pen-
2, Aph-1 or APP substrate), the final determinant of Ab40 or Ab42
generation relies on the molecular conformation of PS1. These
findings strongly support the hypothesis that Ab42/40 ratio is tightly
linked to the conformation of the PS1 molecule, thus making
allosteric modulation of ‘‘pathogenic’’ conformation of PS1 an
attractive target of therapeutic intervention in Alzheimer’s disease.
In addition, we present a ratiometric spectral FRET assay that
can be used for screening drugs modulating Ab42/40 ratio on a
high-throughput screen platform and/or in live mouse brain in
vivo. An additional advantage of using G-PS1-R probe in this assay
Figure 3. Effect of GSMs on G-PS1-R conformation as detected by spectral FRET. HEK293 cells infected with G-PS1-R-lentiviral construct
were treated with either (A) vehicle (DMSO) or 100 mM fenofibrate, or (B) vehicle (EtOH) or 300 mM ibuprofen for 24 hours. After the treatment, cells
were activated by the 488 nm laser and analyzed by spectral FRET. The percentage of cells exhibiting certain 598/513 ratio (Y axis) was plotted
against the 598/513 ratio (X axis). (A) Note that the histogram in the fenofibrate treated cells is shifted to the right of that in DMSO treated cells. This
indicates a higher percentage of cells with elevated 598/513 ratio after the fenofibrate treatment (p,0.001 vs. DMSO; DMSO: n=675 cells,
fenofibrate: n=571cells). (B) Note that higher percentage of cells shows lower 598/513 ratio after the ibuprofen treatment (p,0.001 vs. ethanol;
ethanol: n=730 cells, ibuprofen: n=524cells).
doi:10.1371/journal.pone.0007893.g003
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cells while monitoring cell toxicity of the candidate compounds at
the same time. Finally, the relatively high temporal resolution of
the spectral FRET assay (2–3 seconds per image, compared to 3–4
min per image in the FLIM assay) enables near ‘‘real time’’
monitoring of changes in the PS1/c-secretase conformation
during experimental manipulations.
These data show directly that changes in PS1 conformation can
be detected following various manipulations of PS1 itself, Pen2,
Aph1, APP, and pharmacological agents known as c-secretase
modulators. Together these results strongly support the hypothesis
that c-secretase catalytic specificity can be allosterically modified
via conformational changes in the catalytic PS1 moiety. Therefore,
monitoring PS1 conformation using the G-PS1-R probe could be
a powerful approach to uncover pathological mechanisms leading
to increased Ab42/40 ratio in vitro and in mouse brain in vivo, as well
as a promising tool for therapeutic drug screening of c-secretase
modulating agents.
Materials and Methods
Cell Lines and Pharmacological Treatments
Chinese hamster ovary (CHO) cells and Human embryonic
kidney (HEK) 293 cells were obtained from ATCC (Manassas,
VA). PS1/PS2 double knockout mouse embryonic fibroblasts
(PS1/2 dKO MEF) as well as Aph1ABC
2/2 cells, reconstituted
with either Aph1AL or Aph1B component were previously
described [14,34]. CHO, HEK293 and MEF cells were
maintained in Opti-MEM (Invitrogen) supplemented with 5%
fetal bovine serum. The cells were plated into four-chamber slides
or 35 mm glass-bottom dishes, transfected or infected with various
constructs, and were used for biochemical (Western blot and
ELISA) or microscopy (FLIM, spectral FRET, TIRFM) analyses.
The cells were treated for 24 hours with 100 mM fenofibrate or
400 mM ibuprofen to evaluate the effect of Ab42 –modulating
compounds on PS1 conformation. Dimethylsulfoxide (DMSO) or
ethanol were used as respective vehicle controls.
Constructs and Lenti-Viral Infections
The GFP-PS1-RFP (G-PS1-R) construct was generated as
follows: Human PS1 (NM_000021) was cloned into EGFP-C3
vector using XhoI and HindIII restriction sites to generate N-
terminally (NT) labeled GFP-PS1 construct (G-PS1). A NotI
restriction site was introduced after the G-PS1 codon 351 within
the cytoplasmic loop between transmembrane domains 6 and 7
(TM6-7), resulting in G-PS1NotI construct (based on the cloning
strategy by Drs. Haass and Kaether, Munich, Germany). NotI-
RFP-NotI tag was produced by polymerase chain reaction and
sub-cloned into G-PS1NotI to generate the GFP-PS1-RFP (G-PS1-
R) construct. The familial Alzheimer’s disease L166P PS1
mutation was introduced into the G-PS1-R construct using a
QuickChange site-directed mutagenesis kit (Stratagene, La Jolla,
CA) according to the manufacturer’s instructions. RFP was also
inserted into the loop domain of wtPS1 construct to generate PS1-
R plasmid. The integrity of constructs was confirmed by
sequencing. To increase the efficiency of G-PS1-R construct
delivery to cells, it was packaged into lentivirus (MGH Viral Core
Facility, Director Dr. Miguel Sena-Esteves). For the fluorescent
lifetime imaging microscopy (FLIM) analysis, G-PS1-R lenti-virus
multiplicity of infection, (MOI), was 0.2-1 for CHO, HEK293 and
MEF cells. For the Western blotting of G-PS1-R infected CHO or
MEF cells we used G-PS1-R lentis at MOI 10. Alternatively, a G-
PS1-R encoding plasmid was transfected or co-transfected with
other plasmid constructs as indicated in the manuscript using
Lipofectamine 2000 (Invitrogen). N-terminally truncated Notch 1
receptor construct (NEC), which does not require ligand binding
for its activation and represents an immediate substrate of c-
secretase was a gift from Dr. R. Kopan [35]. Pen2 construct
tagged with Flag on its N-terminus was a gift from Dr.Selkoe
(BWH, Boston, MA). G-PS1 construct as well as EGFP-C3 empty
vector (Clontech, Madison, WI) was used as negative controls for
the Forster resonance energy transfer (FRET) based experiments.
An RFP-GFP fusion (R-G fusion) plasmid in which RFP is fused to
the N-terminus of GFP with a short linker was used as a positive
control in the FRET-based assays.
Western Blot Analysis
For the Western blot analysis CHO or MEF cells plated on
100 mm cell culture dishes were infected with G-PS1-R for 48–
72 hrs. Where NEC needed to be co-expressed, the MEF cells
were co-transfected with NEC 24 hrs prior to the cell harvesting.
The cells were lysed in 1% CHAPSO, and the lysates were
resolved on a 4–20% Tris-Glycine gel. The following antibodies
were used for detection: rabbit anti-APP C-terminus [36](C8,
Selkoe et al., 1988), rabbit anti-GFP (Clontech); mouse anti-PS1
loop (Chemicon), rabbit anti-NICD (Val1744, Cell Signaling).
Enzyme-Linked ImmunoSorbent Assay (ELISA)
For the detection of Ab production, we used PS70 cells, CHO cells
stably transfected with wild type human APP and PS1 [37]. PS70
cells growing in 35 mm cell culture dishes were treated with drugs or
transiently transfected with plasmids encoding either wt Pen-2 or
Flag-Pen-2 using Lipofectamine 2000 reagent (Invitrogen). Sixteen
hoursafterthetransfectioncellsculturemediawasexchangedto1 ml
of Opti-MEM (Invitrogen) supplemented with 2% fetal bovine
serum, and the cells were incubated for additional 24 hours. The cell
culture media for each transfection condition was subjected to the
analysis of human Amyloid b (40) and (42) using ELISA assay kit
(WAKO), according to the manufacturer’s instructions.
Fluorescence Lifetime Imaging Microscopy (FLIM)
A FLIM assay was employed to monitor proximity between the
PS1 NT and TM6-7 loop as an indicator of PS1 conformation in
live cells expressing the G-PS1-R construct. A donor fluorophore
lifetime is an indicator of the proximity between the donor and an
acceptor fluorophore. If the fluorophores are in close proximity to
each other (,10 nm), the GFP donor lifetime decreases due to a
non-radiative transfer of part of its emission energy to the RFP
acceptor (FRET present). GFP fused to the PS1 NT and RFP
located in the PS1 TM6-7 loop serve as FRET donor and acceptor
fluorophores, respectively. The GFP-PS1 construct, in which the
donor lifetime is measured in the absence of an acceptor (FRET
absent), was used as a negative control. GFP-RFP fusion construct
was used as FRET positive control.
Live cells were imaged 2–4 days post-transfection/infection on a
Zeiss LSM510 microscope equipped with 37uC heating chamber
containing 5% CO2. A Chameleon Ti:Sapphire laser was used to
excite the donor fluorophore (two-photon excitation wave length:
840 nm for GFP donor and 800 nm for Alexa488 donor), a high-
speed Hamamatsu (MCP R3809; Hamamatsu, Hamamatsu City,
Japan) detector with very high temporal resolution optimized for
fluorescence lifetime imaging, and Becker&Hickl TCSPC hardware/
software (Becker&Hickl, Berlin, Germany) were used to acquire
donor lifetime information on a pixel-by-pixel basis. Data analysis
was performed using SPC Image (Becker&Hickl, Berlin, Germany),
in which donor fluorophore lifetimes are determined by fitting the
data to one (negative control) or two (experimental conditions)
exponential decay curves. A 1286128 pixel matrix was created to
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images, in which red pixels represent molecules in close proximity
(FRET present), whereas blue pixels represent molecules that are
greater than 10 nm apart from each other (FRET absent).
Alternatively, PS70 cells or CHO cells transfected with
untagged wild type PS1 were fixed in 4% paraformaldehyde and
incubated with antibodies against PS1 NT and C-terminus (CT) or
TM 6–7 loop domain as previously described [21]. PS1 NT was
labeled with Alexa488 (donor) and PS1 CT/PS1 loop with Cy3
(acceptor) to be subjected to the FLIM analysis as described above.
The following antibodies were used for immunostaining; goat anti-
PS1 NT (Sigma), rabbit anti-PS1 CT (Sigma), mouse anti-PS1
loop (Chemicon), donkey anti-goat Alexa 488 (Molecular probe),
donkey anti-rabbit Cy3 (Molecular probe), and donkey anti-mouse
Cy3 (Molecular probe).
Total Internal Reflection Fluorescence Microscopy
(TIRFM)
To test whether G-PS1-R protein traffics through the secretory
pathway and reaches the plasma membrane, we performed a
TIRFM assay. TIRFM detects fluorescent proteins within or in
close proximity (#100 nm) to the plasma membrane of living cells.
The high resolution is achieved by laser beam being totally
reflected on a cell-substrate interface. Thus, only a very thin layer
of the cell immediately adjacent to the interface between two
media is illuminated by the evanescent electromagnetic field. Cells
were transfected with the G-PS1-R constructs and then re-plated a
day before the imaging on a glass cover slip at 30% confluency
using media that did not contain phenol red. The cells were placed
in a CO2 and temperature controlled chamber of Carl Zeiss
system for TIRF imaging. The excitation of EGFP was used to
study presence of the GFP-PS1-RFP expression product within the
proximity of the plasma membrane. Modified Carl Zeiss system
was used to record the images as previously described [38].
Spectral FRET
HEK293 cells in 35 mm glass-bottom dishes were transfected
with PS1 constructs fused with living color tags (G-PS1, G-PS1-R
or L166P G-PS1-R). RFP-GFP fusion construct was used as a
FRET positive control. Cells were imaged 24–48 hours after the
transfection. Spectral imaging was performed on the Zeiss
LSM510 microscope equipped with 37uC heating chamber
containing 5% CO2. The Argon laser at 488 nm was used to
excite GFP, and emitted fluorescence was detected by 7 channels
of the Metadetector with 21.4 nm spectral bandwidth for each
channel that was set to detect fluorescence in the 502–651 nm
wavelength range. The images were processed and quantified
using LSM image browser as follows: average pixel intensity of the
fluorescence in the entire cell was determined for each spectral
window. G-PS1 transfected cells (negative control) showed
maximal fluorescence emission at 513 nm. When FRET occurs,
the energy is transferred from GFP (donor) to RFP (acceptor), thus
the GFP emission peak weakens, and the fluorescence intensity of
RFP increases. The FRET positive control probe (R-G fusion)
showed robust increase in the fluorescence intensity at 598 nm,
compared to that of the FRET negative control (G-PS1). Thus, we
used the ratio of 598 nm (RFP) to 513 nm (GFP) as a readout of
the FRET efficiency, which reflects relative proximity between the
GFP and RFP fluorophores. The ratio value for the whole cell was
calculated as a ratio of average pixel fluorescence intensity at the
598 nm spectral window to that at the 513 nm, after subtraction of
the background fluorescence. We used 10x and 25x objectives for
the average-per-cell analysis, and 63X objective for studying sub-
cellular distribution of PS1. The detector gain and an amplifier
offset were adjusted to make sure that the intensities of cells in the
image were not saturated and the setting maintained the same for
all experimental manipulations. Ratiometric image was produced
by dividing the intensity of the image from the 598 nm spectral
window by that from the 513 nm window after background
subtraction, using Image J. After adjustment of brightness/
contrast, a Look-Up Table was applied by mapping image values
to color-scale (16 colors) resulting in pseudo-color image.
Statistical Analysis
StatView for Windows, Version 5.0.1 (SAS Institute, Inc) was
employed to perform statistical analysis using Fisher’s PSLD
analysis of variance (ANOVA). Samples were considered signif-
icantly different at p,0.05. For the comparison of 598/513 ratio
in spectral FRET assay, a t-test was used for the analysis.
Supporting Information
Figure S1 Expression of G-PS1-R probe in HEK 293 cells. (A–
C) G-PS1-R probe was transfected in HEK293 cells and observed
by conforcal microscopy. GFP (A) as well as RFP signal (B) was
observed mainly in perinuclear area in reticular pattern,
reminiscent of ER distribution. (C) Merged image.
Found at: doi:10.1371/journal.pone.0007893.s001 (1.56 MB TIF)
Figure S2 Conformational diversity of the G-PS1-R molecules in
different subcellular compartments. (A) - Confocal image of the
GFP fluorescence in HEK293 cell infected with G-PS1-R-lenti viral
construct. Several ROIs (circles) were randomly chosen and 598/
513 ratio was calculated for each ROI. The 598/513 ratio in the
each ROI was shown next to the circle. Higher ratio represents
closer GFP-PS1 NT to RFP-PS1-loop proximity. (B)- Spectral
FRET pseudo-colored image is produced by dividing fluorescence
intensity of the image in the 598 spectral window by that in the 513
window on a pixel-by-pixel basis after background subtraction. The
colorimetric scale bar shows 598/513 ratios from 0 (black, GFP and
RFP far apart) to 0.5 (white, GFP-RFP close together). (C) - FLIM
pseudo-color image of the GFP lifetime distribution in HEK293
cells transfected with G-PS1-R. The colorimetric scale bar shows
lifetime in picoseconds. Note red pixels (shorter lifetime) are
predominantly located at/near the cell surface.
Found at: doi:10.1371/journal.pone.0007893.s002 (1.56 MB TIF)
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